Shares of Fresenius Medical Care AG & Co. KGaA (ETR:FME) have earned an average rating of “Buy” from the sixteen research firms that are currently covering the company, MarketBeat.com reports. Six investment analysts have rated the stock with a hold recommendation and ten have given a buy recommendation to the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is €81.84 ($91.96).

A number of equities analysts have recently weighed in on FME shares. Morgan Stanley set a €70.00 ($78.65) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “neutral” rating in a research note on Wednesday, May 20th. JPMorgan Chase & Co. set a €84.20 ($94.61) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research note on Tuesday, May 19th. Jefferies Financial Group set a €70.00 ($78.65) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research note on Monday, June 1st. Warburg Research set a €82.50 ($92.70) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “neutral” rating in a research report on Wednesday, May 6th. Finally, Goldman Sachs Group set a €84.00 ($94.38) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research report on Wednesday, June 10th.

Shares of ETR:FME traded up €1.42 ($1.60) on Tuesday, reaching €78.98 ($88.74). 641,435 shares of the company were exchanged, compared to its average volume of 704,197. The company has a current ratio of 0.91, a quick ratio of 0.61 and a debt-to-equity ratio of 109.85. Fresenius Medical Care AG & Co. KGaA has a 1-year low of €53.50 ($60.11) and a 1-year high of €81.10 ($91.12). The firm has a market cap of $23.17 billion and a price-to-earnings ratio of 19.59. The company has a 50-day moving average of €75.51 and a 200-day moving average of €69.12.

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Read More: How do buyers and sellers choose a strike price?

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.